MiR-122 Targeting with LNA/2'-O-methyl Oligonucleotide Mixmers, Peptide Nucleic Acids (PNA), and PNA-peptide Conjugates

Overview

Journal RNA

Specialty Molecular Biology

Date 2007 Dec 13

PMID 18073344

Citations 127

Authors

Martin M Fabani

Michael J Gait

Affiliations

Soon will be listed here.

Abstract

MicroRNAs are small noncoding RNAs that regulate many cellular processes in a post-transcriptional mode. MicroRNA knockdown by antisense oligonucleotides is a useful strategy to explore microRNA functionality and as potential therapeutics. MicroRNA-122 (miR-122) is a liver-specific microRNA, the main function of which has been linked with lipid metabolism and liver homeostasis. Here, we show that lipofection of an antisense oligonucleotide based on a Locked Nucleic Acids (LNA)/2'-O-methyl mixmer or electroporation of a Peptide Nucleic Acid (PNA) oligomer is effective at blocking miR-122 activity in human and rat liver cells. These oligonucleotide analogs, evaluated for the first time in microRNA inhibition, are more effective than standard 2'-O-methyl oligonucleotides in binding and inhibiting microRNA action. We also show that microRNA inhibition can be achieved without the need for transfection or electroporation of the human or rat cell lines, by conjugation of an antisense PNA to the cell-penetrating peptide R6-Penetratin, or merely by linkage to just four Lys residues, highlighting the potential of PNA for future therapeutic applications as well as for studying microRNA function.

Citing Articles

Enhancing RNA inhibitory activity using clamp-G-modified nucleobases.

Pradeep S, Kumar V, Malik S, Slack F, Gupta A, Bahal R Cell Rep Phys Sci. 2024; 5(8).

PMID: 39421604 PMC: 11484553. DOI: 10.1016/j.xcrp.2024.102120.

Oligonucleotide therapies for nonalcoholic steatohepatitis.

Li S, Xiong F, Zhang S, Liu J, Gao G, Xie J Mol Ther Nucleic Acids. 2024; 35(2):102184.

PMID: 38665220 PMC: 11044058. DOI: 10.1016/j.omtn.2024.102184.

An evolutionary learning-based method for identifying a circulating miRNA signature for breast cancer diagnosis prediction.

Yerukala Sathipati S, Tsai M, Aimalla N, Moat L, Shukla S, Allaire P NAR Genom Bioinform. 2024; 6(1):lqae022.

PMID: 38406797 PMC: 10894035. DOI: 10.1093/nargab/lqae022.

Antisense Therapy for Infectious Diseases.

Buthelezi L, Pillay S, Ntuli N, Gcanga L, Guler R Cells. 2023; 12(16).

PMID: 37626929 PMC: 10453568. DOI: 10.3390/cells12162119.

Recent Development in Biomedical Applications of Oligonucleotides with Triplex-Forming Ability.

Bekkouche I, Shishonin A, Vetcher A Polymers (Basel). 2023; 15(4).

PMID: 36850142 PMC: 9964087. DOI: 10.3390/polym15040858.

References

Baker B, Lot S, Condon T, Lesnik E, Sasmor H, Bennett C . 2'-O-(2-Methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells. J Biol Chem. 1997; 272(18):11994-2000. DOI: 10.1074/jbc.272.18.11994. View

Xue-Wen H, Jie P, Xian-Yuan A, Hong-Xiang Z . Inhibition of bacterial translation and growth by peptide nucleic acids targeted to domain II of 23S rRNA. J Pept Sci. 2007; 13(4):220-6. DOI: 10.1002/psc.835. View

Davis S, Lollo B, Freier S, Esau C . Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res. 2006; 34(8):2294-304. PMC: 1459537. DOI: 10.1093/nar/gkl183. View

Brown D, Arzumanov A, Turner J, Stetsenko D, Lever A, Gait M . Antiviral activity of steric-block oligonucleotides targeting the HIV-1 trans-activation response and packaging signal stem-loop RNAs. Nucleosides Nucleotides Nucleic Acids. 2005; 24(5-7):393-6. DOI: 10.1081/ncn-200059813. View

Turner J, Williams D, Owen D, Gait M . Disulfide conjugation of peptides to oligonucleotides and their analogs. Curr Protoc Nucleic Acid Chem. 2008; Chapter 4:Unit 4.28. DOI: 10.1002/0471142700.nc0428s24. View

Fletcher S, Honeyman K, Fall A, Harding P, Johnsen R, Steinhaus J . Morpholino oligomer-mediated exon skipping averts the onset of dystrophic pathology in the mdx mouse. Mol Ther. 2007; 15(9):1587-92. DOI: 10.1038/sj.mt.6300245. View

Chan J, Krichevsky A, Kosik K . MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005; 65(14):6029-33. DOI: 10.1158/0008-5472.CAN-05-0137. View

Suwanmanee T, Sierakowska H, Fucharoen S, Kole R . Repair of a splicing defect in erythroid cells from patients with beta-thalassemia/HbE disorder. Mol Ther. 2002; 6(6):718-26. DOI: 10.1006/mthe.2002.0805. View

Ahn D, Kourakis M, Rohde L, Silver L, Ho R . T-box gene tbx5 is essential for formation of the pectoral limb bud. Nature. 2002; 417(6890):754-8. DOI: 10.1038/nature00814. View

10.

Naguibneva I, Ameyar-Zazoua M, Nonne N, Polesskaya A, Ait-Si-Ali S, Groisman R . An LNA-based loss-of-function assay for micro-RNAs. Biomed Pharmacother. 2006; 60(9):633-8. DOI: 10.1016/j.biopha.2006.07.078. View

11.

Saetrom P, Heale B, Snove Jr O, Aagaard L, Alluin J, Rossi J . Distance constraints between microRNA target sites dictate efficacy and cooperativity. Nucleic Acids Res. 2007; 35(7):2333-42. PMC: 1874663. DOI: 10.1093/nar/gkm133. View

12.

Cimmino A, Calin G, Fabbri M, Iorio M, Ferracin M, Shimizu M . miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005; 102(39):13944-9. PMC: 1236577. DOI: 10.1073/pnas.0506654102. View

13.

Triboulet R, Mari B, Lin Y, Chable-Bessia C, Bennasser Y, Lebrigand K . Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science. 2007; 315(5818):1579-82. DOI: 10.1126/science.1136319. View

14.

Moschos S, Williams A, Perry M, Birrell M, Belvisi M, Lindsay M . Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids. BMC Genomics. 2007; 8:240. PMC: 1940008. DOI: 10.1186/1471-2164-8-240. View

15.

Sazani P, Gemignani F, Kang S, Maier M, Manoharan M, Persmark M . Systemically delivered antisense oligomers upregulate gene expression in mouse tissues. Nat Biotechnol. 2002; 20(12):1228-33. DOI: 10.1038/nbt759. View

16.

Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T . Identification of tissue-specific microRNAs from mouse. Curr Biol. 2002; 12(9):735-9. DOI: 10.1016/s0960-9822(02)00809-6. View

17.

Liu J, Valencia-Sanchez M, Hannon G, Parker R . MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol. 2005; 7(7):719-23. PMC: 1855297. DOI: 10.1038/ncb1274. View

18.

Jopling C, Norman K, Sarnow P . Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122. Cold Spring Harb Symp Quant Biol. 2007; 71:369-76. DOI: 10.1101/sqb.2006.71.022. View

19.

Arzumanov A, Walsh A, Rajwanshi V, Kumar R, Wengel J, Gait M . Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides. Biochemistry. 2001; 40(48):14645-54. DOI: 10.1021/bi011279e. View

20.

Meister G, Landthaler M, Dorsett Y, Tuschl T . Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA. 2004; 10(3):544-50. PMC: 1370948. DOI: 10.1261/rna.5235104. View